ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
60 951,66
1,06%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Midatech Pharma PLC (MTP)

  7. Midatech Pharma PLC (MTP) Actualités

MTP

Midatech Pharma (MTP)

Midatech Pharma PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:MTP
DateHeureSourceTitreSymboleSociété
24/06/202414h46Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:MTPMidatech Pharma PLC
17/06/202412h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MTPMidatech Pharma PLC
17/06/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTPMidatech Pharma PLC
06/06/202422h05Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:MTPMidatech Pharma PLC
30/04/202403h55Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:MTPMidatech Pharma PLC
15/02/202402h47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTPMidatech Pharma PLC
12/02/202422h30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTPMidatech Pharma PLC
20/12/202322h54Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:MTPMidatech Pharma PLC
14/12/202323h20Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:MTPMidatech Pharma PLC
07/12/202322h15Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:MTPMidatech Pharma PLC
29/06/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MTPMidatech Pharma PLC
28/06/202322h53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MTPMidatech Pharma PLC
22/06/202322h34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MTPMidatech Pharma PLC
20/06/202322h31Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MTPMidatech Pharma PLC
16/06/202314h42Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:MTPMidatech Pharma PLC
07/06/202312h02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTPMidatech Pharma PLC
26/05/202312h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:MTPMidatech Pharma PLC
26/05/202312h03Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:MTPMidatech Pharma PLC
06/03/202315h08Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MTPMidatech Pharma PLC
11/01/202323h05GlobeNewswire Inc.Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of SecurityholdersNASDAQ:MTPMidatech Pharma PLC
19/12/202213h47GlobeNewswire Inc.Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plcNASDAQ:MTPMidatech Pharma PLC
13/12/202218h29GlobeNewswire Inc.Bioasis Technologies Inc. Announces Merger with Midatech Pharma plcNASDAQ:MTPMidatech Pharma PLC
18/10/202222h17Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:MTPMidatech Pharma PLC
26/05/202222h20Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:MTPMidatech Pharma PLC
26/04/202213h23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:MTPMidatech Pharma PLC
30/04/202122h06Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:MTPMidatech Pharma PLC
14/08/202013h07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MTPMidatech Pharma PLC
11/08/202022h01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:MTPMidatech Pharma PLC
10/07/202016h49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTPMidatech Pharma PLC
17/06/202022h30Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:MTPMidatech Pharma PLC
 Showing the most relevant articles for your search:NASDAQ:MTP

Dernières Valeurs Consultées

NASDAQ
AAPL
Apple
EU
PX4
SBF 120
EU
VIV
Vivendi
USI
USTECH100
US Tech 100
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
EU
MC
Lvmh Moet Hennessy Louis...
EU
ML
Michelin
EU
CS
Axa
NASDAQ
NVDA
NVIDIA
EU
AF
Air FranceKLM
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés